[Molecular and pathomorphological prognostic markers for melanoma: Current approaches and prospects].
The incidence of melanoma demonstrates a persistent increasing tendency, which justifies the need to study and identify new prognostic markers for the development and course of this disease. The given paper shows current approaches to melanoma staging, including those to applying pathomorphological prognostic criteria, and discusses prospects for using the results of genomic and epigenomic studies of the carcinoma in clinical practice.
Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of the Russia, Krasnoyarsk.
T G
TG
Ruksha
Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of the Russia, Krasnoyarsk.
M B
MB
Aksenenko
Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of the Russia, Krasnoyarsk.
Yu I
YI
Shvetsova
D014408:Biomarkers, Tumor; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics; D044127:Epigenesis, Genetic; D005819:Genetic Markers; D006801:Humans; D008545:Melanoma / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D035683:MicroRNAs / Q000235:genetics; D009367:Neoplasm Staging; D011379:Prognosis; D012878:Skin Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D059016:Tumor Microenvironment
D014408:Biomarkers, Tumor; D019941:Cyclin-Dependent Kinase Inhibitor p16; D005819:Genetic Markers; D035683:MicroRNAs